Next-IO™ Anti-TIM3 Monoclonal Antibody Program

This program is to develop therapeutic monoclonal antibody against the novel target – —TIM-3 (T-cell immunoglobulin and mucin domain-3). The highlight feature of this program is the powerful therapeutic target – —immune checkpoint TIM-3. With this, we believe this will be a promising program in current bio-pharmaceutical market.

• Reviews
• Related business directories
• Related business listings

5 out of 5 from 1 reviews

Write a review

Overal review:	Excellent Above Average Average Below Average Poor Pleae enter a valid overal review
Type your review: (max 1000 characters)	Pleae enter your review
Verification code:

Biotech company

BioTech Pro

biotech,health,

Pharma Biotech

Biotech companies in kerala

BioTech Pro Male Enhancement

Biotech Pro Reviews

http://healthytalkz.com/biotech-pro/

http://supplementforuse.com/biotech-pro/

http://www.goodforfitness.com/biotech-pro/

http://www.supplementhealthexpert.com/biotech-pro/

http://www.wellness4healthy.com/biotech-pro/

https://fitose.com/biotech-pro/

https://topwellnessblog.com/biotech-pro/

Next-IO™ CD47 × CD19 Therapeutic Bispecific Antibody Program

biotechnology in New York

biotech firms) to develop CD47 × CD19 Dual-Targeting Fusion Protein program together. Our scientists are ...

Anti-Glycan Antibody Development

Anti-Glycan Antibody Development in Shirley

customers produce anti-carbohydrate antibody, including monoclonal antibody and polyclonal antibody ...

Anti-Porcine Circovirus Type 2 Cap Protein Monoclonal Antibody

Biotechnology in NY

NeutraAb™ Anti-Porcine Circovirus Type 2 Cap Protein Monoclonal Antibody